Beneficial effects of suplatast tosilate (IPD‐1151T) in a rat cystitis model induced by intravesical hydrochloric acid
Open Access
- 20 August 2007
- journal article
- Published by Wiley in BJU International
- Vol. 100 (4) , 935-939
Abstract
OBJECTIVE: To examine the effects of suplatast tosilate (IPD‐1151T), a Th2 cytokine inhibitor recently recognized to improve the symptoms in patients with interstitial cystitis (IC), in a rat model of HCl‐induced chronic cystitis, to elucidate the possible mechanisms by which the drug improves the symptoms of IC. MATERIALS AND METHODS: Chronic cystitis was induced by intravesical instillation of 0.2 mL of 0.4 m HCl in female adult rats. After a once‐daily oral administration of IPD‐1151T (0.1–100 mg/kg) or prednisolone (5 mg/kg) for 7 days, cystometry was performed under urethane anaesthesia. The bladder from HCl‐induced cystitis rats was also assessed histopathologically. RESULTS: On cystometrography there was frequent voiding in cystitis rats. Administration of IPD‐1151T for 7 days after intravesical HCl instillation dose‐dependently increased the micturition volume and intercontraction intervals. Treatment with prednisolone had similar therapeutic effects. Histological analyses in the bladder from cystitis rats revealed oedema and infiltration of inflammatory cells such as mast cells and eosinophils in the lamina propria and the transitional epithelial thickening. These histological changes and the number of mast cells and eosinophils were reduced by administration of IPD‐1151T or prednisolone. CONCLUSION: The present results indicate that IPD‐1151T improves bladder function and pathological changes in HCl‐induced cystitis rats, as previously observed in patients with IC. The rat cystitis model induced by HCl could provide useful information for studying proposed therapies for IC which might involve T cell‐dependent inflammatory responses as one of its potential pathophysiologies.Keywords
This publication has 20 references indexed in Scilit:
- Intravesical Suplatast Tosilate (IPD-1151T) Inhibits Experimental Bladder InflammationJournal of Urology, 2007
- Molecular Analysis of Adrenergic Receptor Genes And Interleukin-4/interleukin-4 Receptor Genes in Patients With Interstitial CystitisJournal of Urology, 2002
- IN VIVO MODELS OF INTERSTITIAL CYSTITISJournal of Urology, 2002
- IMPROVEMENT OF INTERSTITIAL CYSTITIS SYMPTOMS AND PROBLEMS THAT DEVELOPED DURING TREATMENT WITH ORAL IPD-1151TJournal of Urology, 2000
- A Molecular Marker for the Development of Interstitial Cystitis in a Rat Model: Isoactin Gene ExpressionJournal of Urology, 1997
- Increased number of substance P positive nerve fibres in interstitial cystitisBritish Journal of Urology, 1995
- Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agentsLife Sciences, 1995
- Activation of Bladder Mast Cells in Interstitial Cystitis: A Light and Electron Microscopic StudyJournal of Urology, 1995
- Activation of Bladder Mast Cells in Interstitial CystitisJournal of Urology, 1995
- Suppression of IgE Production by IPD-1151T (Suplatast Tosilate), a New Dimethylsulfonium Agent: (1) Regulation of Murine IgE ResponseThe Japanese Journal of Pharmacology, 1993